Life Science Fair Flemingsberg – Precision Health

Welcome to Life Science Fair Flemingsberg – a dynamic meeting place where leading life science companies and voices from across the ecosystem come together to showcase, connect, and inspire. Whether you want to network, explore the latest innovations, listen to inspiring talks, or join interactive sessions – this is the place to be.

Each event is designed to highlight the latest across a range of themes – from precision health to medtech, funding, and much more – with keynote speeches, workshops and exhibitions throughout the day. This time: Precision Health! 

Who is it for – and why should you attend?

This day puts the spotlight on precision health, offering a comprehensive view of the field – from research and innovation to health economy, infrastructure, implementation, and emerging trends. Designed for anyone working in or interested in precision health, the day brings together leading voices across academia, industry, and the broader ecosystem to share insights, perspectives, and practical takeaways for applying knowledge and solutions in practice.

The day includes inspiring presentations, panel discussions, and exhibitions, as well as time for mingle and networking throughout the day.

Moderator:

Christina Östberg Lloyd. Christina is a specialist in obstetrics and gynecology, senior life science executive, board professional and women's health advocate with more than 25 years of international leadership experience across clinical care, pharmaceutical development, innovation and governance. Her background includes senior roles at Novo Nordisk, Ferring Pharmaceuticals, Pharmiva and former chair of Swelife, Sweden's strategic innovation program for life science. She is also Chair of VILDA, Women Leading in Life Science.

Program:

09.00 Registration and coffee

09.15 Welcome and introduction

09.30 PMCK – Implementing Precision Medicine in Routine Clinical Care

Andreas Hörnell, Chief of Staff, Precision Medicine Center Karolinska (PMCK)

About: Precision Medicine Center Karolinska (PMCK) is a virtual center dedicated to making precision medicine a part of everyday healthcare. Our mission is to remove barriers and facilitate drive change to bring cutting-edge technologies to every patient, leveraging the unique collaboration between Karolinska University Hospital and Karolinska Institutet.

09.50 Panel discussion

Precision health applies a system‑level approach to care, increasing precision for individual patients while improving how interventions are delivered at a societal level. Advanced therapy medicinal products (ATMPs) are a key driver of this shift, offering new treatment possibilities while challenging existing healthcare structures.

University hospitals play a central role in integrating precision health and ATMPs into clinical practice, supported by strong academic–industry collaboration. However, these developments also require new ways of working — including adapted regulatory frameworks, improved cross‑border processes for clinical studies, better access to data, and clearer coordination between national and regional actors.

Welcome to a panel discussion exploring how healthcare systems can evolve to enable precision health and advanced therapies in routine care.

Panelists: Knut Steffensen, Director at Karolinska ATMP Center, Frida Lundmark, Director of Research Policy at Lif - The Swedish Association of the Pharmaceutical Industry, Malin Eklund, Program Officer at Socialstyrelsen - The National Board of Health and Welfare

10.15 Pause

10.45 Inhaled drug development

Ulf Wedenberg, Chief Commercial Officer, Inhalation Sciences

About: Pre-clinical studies are where the value of an asset is first established. To move the right candidate forward, researchers need reliable and predictive data that minimize clinical risk. Traditional models often fail to accurately predict human outcomes. Inhalation Sciences addresses this challenge by delivering data that better reflects how a drug will perform in humans.

11.05 ExtempoPrint - 3D-printing of compounded medicines

Christina Holmberg, Development Specialist, APL.

About: APL has introduced the ExtempoPrint concept for compounded medicines. 3D printing technology is particularly well suited for pharmacy preparations medicines, as it allows for high dosing accuracy and precision in the formulation. The technology also provides excellent opportunities for individualized dose adjustments. based on the patient's needs.

11.25 Implementing Precision Medicine through SciLifeLab

Rikard Göran Fred, Research Infrastructure Specialist, SciLifeLab

About: The SciLifeLab infrastructure provides cutting-edge technologies to enable excellent research in life science. Through the Clinical Genomics platform, SciLifeLab has already played a major role in implementing precision medicine in Sweden and is now working to improve the accessibility for both academia and industry.

11.45 Designing Machine Learning Models For Liver Digital Pathology In The Absence Of Labels

Fransisco Pena Escobar, Assistant Professor, KTH

Description to follow.

12.00 Lunch and networking

13.00 Genomic Medicine Sweden – advancing precision medicine at the national level

Precision medicine enables the delivery of the most appropriate treatment at the right time, based on individual factors such as a patient’s genetic profile, environment, and lifestyle. New advanced therapies are, in some cases, making it possible to cure conditions that were previously untreatable.However, these treatments may involve high upfront costs. Small patient populations in clinical trials, together with uncertainty around long-term effectiveness, make cost–benefit assessments more complex than for traditional pharmaceuticals. Welcome to this panel discussion exploring the health economic and broader socioeconomic considerations of implementing precision medicine.

Panelists: Peter Lindgren, Managing Director at IHE - The Swedish Institute for Health Economics, Professor of Health Economics at Karolinska Institutet, Fredrik Andersson, Chief Economist at Lif – The Swedish Association of the Pharmaceutical Industry, Anna Alaassad, Chief Strategist at TLV - The Dental and Pharmaceutical Benefits Agency.

Moderators: Andreas Namslauer, Process Manager & Filippa Kull, COO, Stockholm Science City Foundation.

14.00 Pause

14.30 High multiplexing in ddPCR – closing the gap to NGS in precision medicine